shh.sePublikationer
Change search
Refine search result
1 - 20 of 20
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Rows per page
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sort
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
Select
The maximal number of hits you can export is 250. When you want to export more records please use the 'Create feeds' function.
  • 1. Anderbro, Therese
    et al.
    Moberg, E
    Gonder-Frederick, L
    Lins, P E
    Adamson, U
    Johansson, Unn-Britt
    Sophiahemmet University.
    A longitudinal study of fear of hypoglycemia in type 1 diabetes2015Conference paper (Other academic)
  • 2. Eeg-Olofsson, Katarina
    et al.
    Svedbo Engström, Maria
    Borg, Sixten
    Palaszewski, Bo
    Lexell, Janeth
    Johansson, Unn-Britt
    Sophiahemmet University.
    Gudbjörnsdottir, Soffia
    Glycaemic control and patient-reported outcome measures (PROMs) in type 1 diabetes2016Conference paper (Other academic)
  • 3. Freyschuss, Bo
    et al.
    Johansson, Unn-Britt
    Sophiahemmet University.
    Leksell, Janeth
    Steen Carlsson, Katarina
    Thorsén, Håkan
    Werkö, Sophie
    Wikblad, Karin
    Hammarlund, Cecilia
    Johansson, Ida
    Patientutbildning vid diabetes: en systematisk litteraturöversikt2009Report (Other academic)
  • 4. Hanås, R
    et al.
    Lindholm Olinder, A
    Olsson, P.O
    Johansson, Unn-Britt
    Sophiahemmet University.
    Jacobson, S
    Heintz, E
    Werkö, Sophie
    Persson, M
    CSII and SAP valuable tools in the treatment of diabetes: a Swedish health technology assessment2014In: Diabetes Technology & Therapeutics, ISSN 1520-9156, E-ISSN 1557-8593, Vol. 16, no Suppl 1, A-56- p.Article in journal (Refereed)
  • 5.
    Johansson, Unn-Britt
    Sophiahemmet University.
    Sophia Step Study2017Conference paper (Other academic)
  • 6.
    Johansson, Unn-Britt
    et al.
    Sophiahemmet University.
    Hanås, Ragnar
    Olsson, Per-Olof
    Lindholm Olinder, Anna
    Persson, Martina
    Werkö, Sophie
    Jacobson, Stella
    Heintz, Emelie
    Akcan, Derya
    Attergren Granath, Anna
    Davidson, Thomas
    Insulinpumpar vid diabetes2013Report (Other academic)
    Abstract [sv]

    God kontroll av blodglukosnivån är viktig för att undvika följdsjukdomar av diabetes. Vid typ 1-diabetes och en del fall av typ 2-diabetes krävs så kallad intensiv insulinbehandling med flera injektioner per dag. Den vanligaste komplikationen vid denna behandling är lågt blodglukos (hypoglykemi) vilket kan få allvarliga följder [1,2]. Ett alternativ till intensiv insulinbehandling med injektioner är kontinuerlig insulintillförsel med pump, så kallad kontinuerlig subkutan insulininfusion (CSII).

  • 7.
    Johansson, Unn-Britt
    et al.
    Sophiahemmet University.
    Hanås, Ragnar
    Olsson, Per-Olof
    Lindholm Olinder, Anna
    Persson, Martina
    Werkö, Sophie
    Jacobson, Stella
    Heintz, Emelie
    Akcan, Derya
    Attergren Granath, Anna
    Davidson, Thomas
    Kontinuerlig subkutan glukosmätning vid diabetes2013Report (Other academic)
    Abstract [sv]

    God kontroll av blodglukosnivån är viktig för att undvika följdsjukdomar av diabetes. Blodglukos kan mätas av patienten själv med teststickor (self monitoring of blood glucose, SMBG) eller via en subkutan sensor (kontinuerlig subkutan glukosmätning, CGM). Vid typ 1-diabetes behövs rutinmässigt upprepade blodglukosmätningar varje dygn för att uppnå god glukoskontroll.

    SBU har utvärderat nytta och risk av behandling med kontinuerlig glukosmätning utan eller med insulinpump (SAP) vid diabetes hos barn, ungdomar och vuxna. I utvärderingen ingår också en hälsoekonomisk och etisk analys, samt en stor praxisundersökning som omfattade samtliga diabeteskliniker i Sverige

  • 8.
    Johansson, Unn-Britt
    et al.
    Sophiahemmet University.
    Wredling, Regina
    Sophiahemmet University.
    Adamson, Ulf
    Lins, Per-Eric
    A morning dose of insulin glargine prevents nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion with insulin lispro2007In: Diabetes & Metabolism, ISSN 1262-3636, E-ISSN 1878-1780, Vol. 33, no 6, 469-71 p.Article in journal (Refereed)
    Abstract [en]

    AIM: The aim of this crossover trial was to evaluate the potential of partial substitution of basal insulin with glargine, administered once daily in the morning, to protect against nocturnal ketosis after postprandial interruption of continuous subcutaneous insulin infusion (CSII). METHODS: Seven patients with type 1 diabetes received 4 weeks of treatment with insulin lispro, administered by CSII, and 4 weeks of treatment with CSII and a partial basal replacement dose of insulin glargine administered in the morning. On day 28 of each treatment phase, patients were admitted to the research unit where dinner was served and their usual dinner insulin bolus dose given, after which CSII was discontinued at 7 pm. Plasma (p) beta-hydroxybutyrate and p glucose were measured every hour for 12 h thereafter. RESULTS: Plasma beta-hydroxybutyrate at 7 pm was 0.16+/-0.05 and 0.13+/-0.07 mmol/l with and without glargine, respectively, and increased to 0.17+/-0.10 and 0.60+/-0.3 mmol/l within 6 h (P=0.02). Plasma glucose increased without glargine, from 8.6+/-2.9 to 21.1+/-3.0 mmol/l (P=0.003), but did not rise significantly following glargine (13.6+/-4.7 vs. 12.6+/-5.6 mmol/l; P=0.65). CONCLUSIONS: Partial replacement with a morning dose of insulin glargine protects against the development of ketosis for as much as 12 h after postprandial interruption of CSII. This treatment strategy could, therefore, be useful for patients who are prone to ketosis but, for other reasons, are deemed suitable for CSII.

  • 9. Lindholm Olinder, A
    et al.
    Hanås, R
    Heintz, E
    Jacobson, S
    Johansson, Unn-Britt
    Sophiahemmet University.
    Olsson, P.O
    Persson, M
    Werkö, Sophie
    CGM and SAP are valuable tools in the treatment of diabetes: a Swedish health technology assessment2014In: Diabetes Technology & Therapeutics, ISSN 1520-9156, E-ISSN 1557-8593, Vol. 16, no Suppl 1, A-74- p.Article in journal (Refereed)
  • 10. Mc Laughlin, Sue
    et al.
    Chaney, David
    Belton, Anne
    Garst, Jilde
    International standards for education of diabetes health professionals2015Book (Other academic)
  • 11.
    Rossen, Jenny
    Sophiahemmet University.
    "But now it is a habit": Participants' experiences of Sophia Step Study2017Conference paper (Other academic)
  • 12.
    Rossen, Jenny
    et al.
    Sophiahemmet University.
    Buman, Matthew P
    Johansson, Unn-Britt
    Sophiahemmet University.
    Yngve, Agneta
    Sophiahemmet University.
    Ainsworth, Barbara
    Brismar, Kerstin
    Hagströmer, Maria
    Reallocating bouted sedentary time to non-bouted sedentary time, light activity and moderate-vigorous physical activity in adults with prediabetes and type 2 diabetes2017In: PLoS ONE, ISSN 1932-6203, E-ISSN 1932-6203, Vol. 12, no 7, e0181053Article in journal (Refereed)
    Abstract [en]

    AIM: The aim of this study was to investigate the potential associations of reallocating 30 minutes sedentary time in long bouts (>60 min) to sedentary time in non-bouts, light intensity physical activity (LPA) and moderate- to vigorous physical activity (MVPA) with cardiometabolic risk factors in a population diagnosed with prediabetes or type 2 diabetes.

    METHODS: Participants diagnosed with prediabetes and type 2 diabetes (n = 124, 50% men, mean [SD] age = 63.8 [7.5] years) were recruited to the physical activity intervention Sophia Step Study. For this study baseline data was used with a cross-sectional design. Time spent in sedentary behaviors in bouts (>60 min) and non-bouts (accrued in <60 min bouts) and physical activity was measured using the ActiGraph GT1M. Associations of reallocating bouted sedentary time to non-bouted sedentary time, LPA and MVPA with cardiometabolic risk factors were examined using an isotemporal substitution framework with linear regression models.

    RESULTS: Reallocating 30 minutes sedentary time in bouts to MVPA was associated with lower waist circumference (b = -4.30 95% CI:-7.23, -1.38 cm), lower BMI (b = -1.46 95% CI:-2.60, -0.33 kg/m2) and higher HDL cholesterol levels (b = 0.11 95% CI: 0.02, 0.21 kg/m2. Similar associations were seen for reallocation of sedentary time in non-bouts to MVPA. Reallocating sedentary time in bouts to LPA was associated only with lower waist circumference.

    CONCLUSION: Reallocation of sedentary time in bouts as well as non-bouts to MVPA, but not to LPA, was beneficially associated with waist circumference, BMI and HDL cholesterol in individuals with prediabetes and type 2 diabetes. The results of this study confirm the importance of reallocation sedentary time to MVPA.

  • 13.
    Rossen, Jenny
    et al.
    Sophiahemmet University.
    Johansson, Unn-Britt
    Sophiahemmet University.
    Hagströmer, Maria
    Yngve, Agneta
    Sophiahemmet University.
    Sophia Step Study: en metod för att öka patienternas fysiska aktivitetsnivå2016In: BestPractice Diabets/Hjärt-kärlsjukdomar, Vol. 6, no 19, 16-18 p.Article in journal (Other (popular science, discussion, etc.))
  • 14.
    Rossen, Jenny
    et al.
    Sophiahemmet University.
    Johansson, Unn-Britt
    Sophiahemmet University.
    Lööf, Helena
    Sophiahemmet University.
    Hagströmer, Maria
    Yngve, Agneta
    Exploration of study participants experiences following Sophia Step Study: A two-year physical activity intervention2016Conference paper (Other academic)
  • 15.
    Rossen, Jenny
    et al.
    Sophiahemmet University.
    Lööf, Helena
    Yngve, Agneta
    Hagströmer, Maria
    Brismar, Kerstin
    Johansson, Unn-Britt
    Sophiahemmet University.
    Support for self-management of physical activity in persons with prediabetes and type 2 diabetes: Experiences from Sophia Step Study2017Conference paper (Other academic)
  • 16.
    Rossen, Jenny
    et al.
    Sophiahemmet University.
    Lööf, Helena
    Sophiahemmet University.
    Yngve, Agneta
    Sophiahemmet University.
    Hagströmer, Maria
    Brismar, Kerstin
    Johansson, Unn-Britt
    Sophiahemmet University.
    Using pedometers for self-management of physical activity: Participants' experiences from Sophia Step Study: A physical activity promotion intervention in pre- and type 2 diabetes2017Conference paper (Other academic)
  • 17.
    Rossen, Jenny
    et al.
    Sophiahemmet University.
    Yngve, Agneta
    Sophiahemmet University.
    Hagströmer, M
    Brismar, Kerstin
    Ainsworth, B
    Möller, P
    Iskull, C
    Johansson, Unn-Britt
    Sophiahemmet University.
    Sophia step study: An RCT using pedometers to increase daily steps in subjects with pre and type 2 diabetes2015Conference paper (Other academic)
  • 18. Svedbo Engström, Maria
    et al.
    Leksell, Janeth
    Johansson, Unn-Britt
    Sophiahemmet University.
    Eeg-Olofsson, Katarina
    Borg, Sixten
    Palaszewski, Bo
    Gudbjörnsdottir, Soffia
    A disease-specific questionnaire for measuring patient-reported outcomes and experiences in the Swedish National Diabetes Register: Development and evaluation of content validity, face validity, and test-retest reliability2017In: Patient Education and Counseling, ISSN 0738-3991, E-ISSN 1873-5134, S0738-3991(17)30429-9Article in journal (Refereed)
    Abstract [en]

    OBJECTIVE: To describe the development and evaluation of the content and face validity and test-retest reliability of a disease-specific questionnaire that measures patient-reported outcomes and experiences for the Swedish National Diabetes Register for adult patients who have type 1 or type 2 diabetes.

    METHODS: In this methodological study, a questionnaire was developed over four phases using an iterative process. Expert reviews and cognitive interviews were conducted to evaluate content and face validity, and a postal survey was administered to evaluate test-retest reliability.

    RESULTS: The expert reviews and cognitive interviews found the disease-specific questionnaire to be understandable, with relevant content and value for diabetes care. An item-level content validity index ranged from 0.6-1.0 and a scale content validity/average ranged from 0.7-1.0. The fourth version, with 33 items, two main parts and seven dimensions, was answered by 972 adults with type 1 and type 2 diabetes (response rate 61%). Weighted Kappa values ranged from 0.31-0.78 for type 1 diabetes and 0.27-0.74 for type 2 diabetes.

    CONCLUSIONS: This study describes the initial development of a disease-specific questionnaire in conjunction with the NDR. Content and face validity were confirmed and test-retest reliability was satisfactory.

    PRACTICE IMPLICATIONS: With the development of this questionnaire, the NDR becomes a clinical tool that contributes to further understanding the perspectives of adult individuals with diabetes.

  • 19. Svedbo Engström, Maria
    et al.
    Leksell, Janeth
    Johansson, Unn-Britt
    Sophiahemmet University.
    Gudbjörnsdottir, Soffia
    Development of a patient reported outcome measure for the Swedish national diabetes register2016Conference paper (Other academic)
  • 20.
    Svedbo Engström, Maria
    et al.
    Högskolan Dalarna.
    Leksell, Janeth
    Högskolan Dalarna.
    Johansson, Unn-Britt
    Sophiahemmet University.
    Gudbjörnsdóttir, Soffia
    Göteborgs universitet.
    Utveckling av patientrapporterade utfallsmått (PROM) för NDR. I: Nationella Diabetesregistret - Årsrapport 2012 års resultat2013Other (Other academic)
1 - 20 of 20
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf